71P A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: Preliminary safety, efficacy and PK/PD results
Titel:
71P A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: Preliminary safety, efficacy and PK/PD results
Auteur:
Zandberg, D.P. Ferris, R. Laux, D. Mehra, R. Nabell, L. Kaczmar, J. Gibson, M.K. Kim, Y.J. Neupane, P. Bauman, J. Julian, R. Adkins, D. Cohen, E. Burtness, B. Bermingham, C. Dupage, A. Desbien, A. Loi, A. Nuyten, D.S.A. Saba, N.F.